Legal & General Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $894M | Buy |
10,316,815
+134,932
| +1% | +$12.9M | 0.21% | 87 |
|
|
2025
Q4 | $978M | Buy |
10,181,883
+698,172
| +7% | +$67.8M | 0.22% | 85 |
|
|
2025
Q3 | $903M | Buy |
9,483,711
+827,530
| +10% | +$76.1M | 0.2% | 88 |
|
|
2025
Q2 | $755M | Sell |
8,656,181
-616,137
| -7% | -$52.3M | 0.19% | 100 |
|
|
2025
Q1 | $833M | Buy |
9,272,318
+70,993
| +0.8% | +$6.35M | 0.23% | 81 |
|
|
2024
Q4 | $735M | Sell |
9,201,325
-332,522
| -3% | -$28.8M | 0.19% | 91 |
|
|
2024
Q3 | $858M | Buy |
9,533,847
+275,944
| +3% | +$23.2M | 0.23% | 81 |
|
|
2024
Q2 | $729M | Sell |
9,257,903
-414,579
| -4% | -$34M | 0.21% | 91 |
|
|
2024
Q1 | $843M | Sell |
9,672,482
-94,580
| -1% | -$8.07M | 0.24% | 74 |
|
|
2023
Q4 | $805M | Sell |
9,767,062
-145,913
| -1% | -$11.1M | 0.25% | 71 |
|
|
2023
Q3 | $777M | Sell |
9,912,975
-301,404
| -3% | -$25.2M | 0.27% | 64 |
|
|
2023
Q2 | $900M | Buy |
10,214,379
+518,483
| +5% | +$44.6M | 0.29% | 57 |
|
|
2023
Q1 | $782M | Buy |
9,695,896
+71,558
| +0.7% | +$5.83M | 0.28% | 63 |
|
|
2022
Q4 | $748M | Sell |
9,624,338
-453,649
| -5% | -$36.8M | 0.29% | 70 |
|
|
2022
Q3 | $814M | Sell |
10,077,987
-322,973
| -3% | -$29M | 0.32% | 55 |
|
|
2022
Q2 | $933M | Buy |
10,400,960
+292,575
| +3% | +$29.6M | 0.33% | 56 |
|
|
2022
Q1 | $1.12B | Buy |
10,108,385
+700,092
| +7% | +$74M | 0.34% | 50 |
|
|
2021
Q4 | $973M | Sell |
9,408,293
-303,715
| -3% | -$35.2M | 0.29% | 57 |
|
|
2021
Q3 | $1.22B | Buy |
9,712,008
+400,444
| +4% | +$51.8M | 0.4% | 45 |
|
|
2021
Q2 | $1.16B | Buy |
9,311,564
+335,638
| +4% | +$42.1M | 0.39% | 45 |
|
|
2021
Q1 | $1.06B | Sell |
8,975,926
-180,970
| -2% | -$21.2M | 0.4% | 45 |
|
|
2020
Q4 | $1.07B | Buy |
9,156,896
+19,121
| +0.2% | +$2.1M | 0.42% | 43 |
|
|
2020
Q3 | $949M | Sell |
9,137,775
-140,607
| -2% | -$14.1M | 0.42% | 44 |
|
|
2020
Q2 | $851M | Sell |
9,278,382
-93,012
| -1% | -$8.92M | 0.41% | 48 |
|
|
2020
Q1 | $846M | Buy |
9,371,394
+305,954
| +3% | +$32.5M | 0.49% | 36 |
|
|
2019
Q4 | $1.03B | Buy |
9,065,440
+134,770
| +2% | +$14.8M | 0.49% | 32 |
|
|
2019
Q3 | $970M | Sell |
8,930,670
-26,678
| -0.3% | -$2.78M | 0.51% | 33 |
|
|
2019
Q2 | $872M | Sell |
8,957,348
-14,828
| -0.2% | -$1.35M | 0.47% | 36 |
|
|
2019
Q1 | $817M | Buy |
8,972,176
+1,605,788
| +22% | +$144M | 0.47% | 38 |
|
|
2018
Q4 | $670M | Buy |
7,366,388
+440,229
| +6% | +$41.1M | 0.52% | 34 |
|
|
2018
Q3 | $681M | Buy |
6,926,159
+101,574
| +1% | +$9.39M | 0.49% | 34 |
|
|
2018
Q2 | $585M | Sell |
6,824,585
-225,864
| -3% | -$18.9M | 0.45% | 39 |
|
|
2018
Q1 | $565M | Buy |
7,050,449
+78,638
| +1% | +$6.49M | 0.43% | 43 |
|
|
2017
Q4 | $563M | Sell |
6,971,811
-166,924
| -2% | -$13.4M | 0.41% | 45 |
|
|
2017
Q3 | $555M | Buy |
7,138,735
+149,801
| +2% | +$12.4M | 0.42% | 45 |
|
|
2017
Q2 | $620M | Buy |
6,988,934
+93,595
| +1% | +$7.89M | 0.5% | 38 |
|
|
2017
Q1 | $555M | Buy |
6,895,339
+217,257
| +3% | +$17M | 0.47% | 36 |
|
|
2016
Q4 | $476M | Buy |
+6,678,082
| New | +$525M | 0.44% | 41 |
|
|
2015
Q1 | – | Sell |
-4,203,142
| Closed | -$304M | – | 2790 |
|
|
2014
Q4 | $304M | Sell |
4,203,142
-96,159
| -2% | -$6.68M | 0.36% | 64 |
|
|
2014
Q3 | $266M | Sell |
4,299,301
-143,874
| -3% | -$9.15M | 0.32% | 69 |
|
|
2014
Q2 | $283M | Buy |
4,443,175
+27,963
| +0.6% | +$1.7M | 0.33% | 69 |
|
|
2014
Q1 | $272M | Sell |
4,415,212
-88,737
| -2% | -$5.17M | 0.33% | 68 |
|
|
2013
Q4 | $258M | Sell |
4,503,949
-17,030
| -0.4% | -$966K | 0.31% | 75 |
|
|
2013
Q3 | $241M | Sell |
4,520,979
-45,631
| -1% | -$2.46M | 0.32% | 71 |
|
|
2013
Q2 | $235M | Buy |
+4,566,610
| New | +$226M | 0.32% | 68 |
|
Other funds holding MDT
VCM
VPM
Legal & General Group's MDT Position: Q1 2026 in Review
Legal & General Group increased its Medtronic (MDT) stake by 1.3% in Q1 2026, buying an estimated $12.9M and bringing the position to 10,316,815 shares worth $894M. The position accounts for 0.21% of the portfolio, ranked #87.
Legal & General Group first reported a position in MDT in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.22B in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Legal & General Group held 10,316,815 shares of Medtronic worth $894M as of Q1 2026.
- Legal & General Group bought 134,932 Medtronic shares in Q1 2026, an estimated $12.9M.
- Medtronic made up 0.21% of Legal & General Group's portfolio in Q1 2026, its #87 holding.
- Legal & General Group first reported a position in Medtronic in Q2 2013 and has held it in 45 quarters since.
- Legal & General Group's Medtronic position peaked at $1.22B in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.